Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

2.546 +0.227 (+9.76%)
Streaming Delayed Price Updated: 11:21 AM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... 
Via Benzinga
Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading ↗
U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,... 
Via Benzinga
News headline image
Earnings Scheduled For May 10, 2021 ↗
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
News headline image
Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal ↗
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average... 
Via Benzinga
News headline image
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today ↗
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is... 
Via Benzinga
News headline image
Inovio Pharmaceuticals Insights: Return On Capital Employed ↗
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
News headline image
Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global... 
Via Benzinga
News headline image
48 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... 
Via Benzinga
News headline image
These Vaccine Latecomers Could Still Win Big. Here's How ↗
The key is standing out from the crowd. 
Via The Motley Fool
Topics Cannabis
News headline image
Why Inovio Pharmaceuticals Stock Perked Up in May ↗
The biotech's pan-COVID-19 vaccine caught the eye of investors last month. 
Via The Motley Fool
News headline image
I Would Hope Inovio Isn’t Attracting ANY Serious Money ↗
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
News headline image
Is It Too Late to Buy Inovio Pharmaceuticals Stock? ↗
This troubled coronavirus vaccine developer has created far more woes than joys for investors. 
Via The Motley Fool
News headline image
Step Aside AMC: Here Are The Most Shorted Stocks Right Now ↗
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
News headline image
Ocugen vs. Inovio: Where Is the Smart Money Going? ↗
They're both seeking share in the vaccine market. 
Via The Motley Fool
News headline image
Inovio's Latest COVID Vaccine Results: Too Little, Too Late? ↗
Maybe not -- especially outside of the U.S. 
Via The Motley Fool
News headline image
2 Things That May Boost This Beaten-Down Vaccine Stock ↗
This company could benefit from a near-term need -- and a long-term one, as well. 
Via The Motley Fool
News headline image
High Flyers At Much Lower Altitudes ↗
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
Via Talk Markets
News headline image
1 Coronavirus Vaccine Company to Avoid Like The Plague in May (and Beyond) ↗
This biotech's prospects look dim. 
Via The Motley Fool
News headline image
Inovio's Pan-COVID-19 Vaccine Candidate Can Provide Immune Responses Against Variants, Animal Study Shows ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced results from a preclinical study of its next-generation Pan-COVID-19 vaccine candidate, INO-4802, that... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints ↗
Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar... 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript ↗
INO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Inovio Pharmaceuticals Q1 Earnings ↗
Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... 
Via Benzinga
News headline image
Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.